Results for the substance tafamidis

Tafamidis is a transthyretin stabilizer used for the treatment of transthyretin amyloidosis (ATTR), a rare condition affecting the heart and nervous system. It works by stabilizing the transthyretin protein, preventing the formation of amyloid deposits.

The medication is taken orally, usually once daily, as directed by a doctor. It is important for patients to follow the prescribed dosage and undergo regular medical check-ups to monitor disease progression.

Patients should be aware of potential side effects, such as fatigue, nausea, or diarrhea. It is important to inform the doctor of any unusual symptoms.

Common side effects include fatigue, nausea, diarrhea, and abdominal pain. In rare cases, allergic reactions or liver function impairment may occur. Patients should be informed of these risks before starting treatment.